SUSQUEHANNA INTERNATIONAL GROUP, LLP
Position in INBX — Inhibrx Biosciences, Inc.
CIK 1446194
BALA CYNWYD, PA
Position in INBX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$6,580,001
-$16,892,163 QoQ
Shares Held
97,873
-67.1% QoQ
Ownership
0.667%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INBX Over Time
Shares Held
Position Value (USD)
Derivatives in INBX
reported options exposure · as of Mar 31, 2026CallValue
$3,549,744
CallShares
52,800
PutValue
$450,441
PutShares
6,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $1,159,899,084 across 353 Biotechnology names. INBX ranks #42 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
898,951 | $59,249,860 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
174,268 | $57,660,053 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
1,344,953 | $45,499,759 | |
| 4 | ABVX |
Abivax S.A.
|
381,282 | $42,455,750 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
398,943 | $29,625,507 | |
| 6 | INSM |
INSMED Inc
|
173,630 | $28,391,977 | |
| 7 | CRSP |
CRISPR Therapeutics AG
|
593,406 | $28,228,323 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
521,571 | $27,497,223 |
All Filings in INBX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,580,001 | 97,873 | Shares | Other | 2026-05-15 | |
| 2026-03-31 | $3,549,744 | 52,800 | Call | Other | 2026-05-15 | |
| 2026-03-31 | $450,441 | 6,700 | Put | Other | 2026-05-15 | |
| 2025-12-31 | $23,472,164 | 297,116 | Shares | Other | 2026-02-17 | |
| 2025-12-31 | $16,605,800 | 210,200 | Put | Other | 2026-02-17 | |
| 2025-12-31 | $9,882,900 | 125,100 | Call | Other | 2026-02-17 | |
| 2025-09-30 | $693,808 | 20,600 | Call | Other | 2025-11-14 | |
| 2025-06-30 | $329,251 | 23,073 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $739,693 | 52,873 | Shares | Other | 2025-05-14 | |
| 2025-03-31 | $496,645 | 35,500 | Call | Other | 2025-05-14 | |
| 2024-12-31 | $177,100 | 11,500 | Put | Other | 2025-02-14 | |
| 2024-12-31 | $295,680 | 19,200 | Call | Other | 2025-02-14 | |
| 2024-12-31 | $1,115,760 | 72,452 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $1,556,118 | 99,369 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $560,628 | 35,800 | Call | Defined | 2024-11-14 | |
| 2024-09-30 | $220,806 | 14,100 | Put | Defined | 2024-11-14 | |
| 2024-06-30 | $1,806,675 | 127,500 | Shares | Defined | 2024-08-15 | |
| 2024-06-30 | $252,226 | 17,800 | Call | Defined | 2024-08-15 | |
| 2024-06-30 | $192,712 | 13,600 | Put | Defined | 2024-08-15 | |
| No filing history on record for this holder in this stock. | ||||||